Rooming-In to Treat Neonatal Abstinence Syndrome: Improved Family-Centered Care at Lower Cost
- 18 May 2016
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 137 (6) , e20152929
Abstract
BACKGROUND AND OBJECTIVE: The incidence and associated costs of neonatal abstinence syndrome (NAS) have recently risen sharply; newborns with NAS occupy 4% of NICU beds. We implemented a coordinated program for NAS including standardized protocols for scoring, medications and weaning, and a calm rooming-in environment, to improve family-centered care and to decrease both length of stay (LOS) and hospital costs. METHODS: In early 2013, a multidisciplinary quality improvement team began consecutive plan-do-study-act (PDSA) cycles. We trained nurses in modified Finnegan scoring, ensured scoring only after on-demand feeds during skin-to-skin care, and standardized physician score interpretation. We provided prenatal family education, increased family involvement in symptom monitoring and nonpharmacologic treatment, and treated otherwise healthy infants on the inpatient pediatric unit instead of in the NICU. We measured outcomes using statistical process control methods. RESULTS: At baseline, 46% of inborn infants at-risk for NAS were treated with morphine; by 2015, this decreased to 27%. Adjunctive use of phenobarbital decreased from 13% to 2% in the same period. Average LOS for morphine-treated newborns decreased from 16.9 to 12.3 days, average hospital costs per treated infant decreased from $19 737 to $8755, and costs per at-risk infant dropped from $11 000 to $5300. Cumulative morphine dose decreased from 13.7 to 6.6 mg per treated newborn. There were no adverse events, and 30-day readmission rates remained stable. CONCLUSIONS: A coordinated, standardized NAS program safely reduced pharmacologic therapy, LOS, and hospital costs. Rooming-in with family and decreased use of NICU beds were central to achieved outcomes.Keywords
This publication has 22 references indexed in Scilit:
- Erratum: Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012Journal of Perinatology, 2015
- Increasing Incidence of the Neonatal Abstinence Syndrome in U.S. Neonatal ICUsNew England Journal of Medicine, 2015
- A Multicenter Cohort Study of Treatments and Hospital Outcomes in Neonatal Abstinence SyndromePediatrics, 2014
- Neonatal Abstinence SyndromePediatrics, 2014
- Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004–2011Journal of Perinatology, 2014
- Neonatal Opiate Withdrawal and Rooming-In: A Retrospective Analysis of a Single Center ExperienceKlinische Padiatrie, 2013
- Neonatal Abstinence Syndrome and Associated Health Care ExpendituresJAMA, 2012
- Neonatal abstinence syndrome—postnatal ward versus neonatal unit managementEuropean Journal of Pediatrics, 2009
- Effects of Breast Milk on the Severity and Outcome of Neonatal Abstinence Syndrome Among Infants of Drug-Dependent MothersPediatrics, 2006
- A RETROSPECTIVE STUDY OF LENGTH OF HOSPITAL STAY IN INFANTS TREATED FOR NEONATAL ABSTINENCE SYNDROME WITH METHADONE VERSUS ORAL MORPHINE PREPARATIONSAdvances in Neonatal Care, 2005